AZD6482

DRUG2 trials

Sponsors

AstraZeneca

Conditions

Antiplatelet Effect

Phase 1

Study to Investigate Safety and Tolerability of a Single Dose of AZD6482

CompletedNCT00688714

AstraZenecaAntiplatelet Effect

Start: 2008-01-31End: 2008-05-31Updated: 2008-06-03

Bleeding Time Study With AZD6482, Clopidogrel and ASA

CompletedNCT00853450

AstraZenecaAntiplatelet Effect

Start: 2009-02-28End: 2009-07-31Target: 28Updated: 2009-08-19